Lilly to Participate in the J.P. Morgan Healthcare Conference
Eli Lilly and Company (NYSE: LLY) will participate in the 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023. CEO David A. Ricks will engage in a fireside chat at 6:45 p.m. Eastern time. The session will be available via live audio webcast on Lilly's Investor website, with a replay accessible for 90 days afterwards. Lilly has a long history of innovation, helping over 47 million people globally through advanced medicines. The company focuses on addressing significant health challenges, including diabetes and Alzheimer's.
- None.
- None.
INDIANAPOLIS, Jan. 4, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will attend the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 10, 2023. David A. Ricks, Lilly's chair and CEO, will participate in a fireside chat at 6:45 p.m. Eastern time.
A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's Investor website at https://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days.
About Lilly
Lilly unites caring with discovery to create medicines that make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 47 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer's disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/newsroom or follow us on Facebook, Instagram and LinkedIn. F-LLY
Refer to: | Jordan Bishop; jordan.bishop@lilly.com; 317-473-5712 (Media) |
Joe Fletcher; jfletcher@lilly.com; 317-296-2884 (Investors) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-to-participate-in-the-jp-morgan-healthcare-conference-301712815.html
SOURCE Eli Lilly and Company
FAQ
When is Eli Lilly participating in the J.P. Morgan Healthcare Conference?
What time is Eli Lilly's CEO speaking at the J.P. Morgan Healthcare Conference?
How can investors listen to Eli Lilly's presentation at the conference?
Where can I find the replay of Eli Lilly's conference presentation?
What health challenges does Eli Lilly focus on?
